Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stargazin involvement with bipolar disorder and response to lithium treatment.

Pharmacogenetics and genomics - 1 May 2008

Silberberg Gilad, Levit Anat, Collier David, St Clair David, Munro Janet, Kerwin Robert W, Tondo Leonardo, Floris Gianfranco, Breen Gerome, Navon Ruth

Abstract excerpt

OBJECTIVES: Multiple reports have implicated chromosomal region 22q13.1 in both schizophrenia and bipolar disorder. The calcium channel gamma-2 subunit gene (cacng2, Stargazin) located on 22q13.1 was recently reported to be associated with schizophrenia. We aimed to examine the expression levels of Stargazin in post-mortem brain samples of patients with schizophrenia, patients with bipolar disorder (BPD) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Bipolar Disorder

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calcium Channels

Share to Cohort Studies

Share to Drug Resistance

Share to Gene Expression

Share to Linkage Disequilibrium

Share to Schizophrenia

Source

Identifiers

PMID: 18408563
DOI: 10.1097/FPC.0b013e3282f974ca

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stargazin involvement with bipolar disorder and response to lithium treatment.PMID 18408563Read ↗

GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlations.Semantic proximity Read ↗

Exploring lithium’s transcriptional mechanisms of action in bipolar disorder: a multi-step studySemantic proximity Read ↗

The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research PerspectivesSemantic proximity Read ↗

Pharmacogenomics of Lithium Response in Bipolar DisorderSemantic proximity Read ↗

Lithium Pharmacogenetics: Where Do We Stand?Semantic proximity Read ↗

Family-based association study of lithium-related and other candidate genes in bipolar disorder.Semantic proximity Read ↗

Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia.Semantic proximity Read ↗

Cellular genome wide association study identifies common genetic variation influencing lithium induced neural progenitor proliferationSemantic proximity Read ↗

Lithium response in bipolar disorder: Genetics, genomics, and beyondSemantic proximity Read ↗

Genetic and Epigenetic Markers of Lithium ResponseSemantic proximity Read ↗

Relationship between GABRB2 gene polymorphisms and schizophrenia susceptibility: a case-control study and in silico analyses.Semantic proximity Read ↗

A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.